Matches in Wikidata for { <http://www.wikidata.org/entity/Q65358147> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q65358147 description "clinical trial" @default.
- Q65358147 description "ensayu clínicu" @default.
- Q65358147 description "klinisch onderzoek" @default.
- Q65358147 description "клінічне випробування" @default.
- Q65358147 name "A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer" @default.
- Q65358147 name "A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer" @default.
- Q65358147 type Item @default.
- Q65358147 label "A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer" @default.
- Q65358147 label "A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer" @default.
- Q65358147 prefLabel "A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer" @default.
- Q65358147 prefLabel "A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer" @default.
- Q65358147 P1132 Q65358147-8ECED21C-2474-4559-A660-4BB05A0B381F @default.
- Q65358147 P1476 Q65358147-C11AA713-2DC1-4F19-B104-2F400C5908C2 @default.
- Q65358147 P17 Q65358147-420B8E16-736A-46FB-85D5-44E27B56EF61 @default.
- Q65358147 P2899 Q65358147-77885A27-3017-4DFA-BEF5-54ABD3A091AA @default.
- Q65358147 P3098 Q65358147-79E9FBA8-79D3-4EAC-B277-A0754161D126 @default.
- Q65358147 P31 Q65358147-0FDCB359-D76D-48D3-8EEA-682AE63E9AF4 @default.
- Q65358147 P580 Q65358147-14C5ED1F-19EA-4834-A57B-260EBA4B0C31 @default.
- Q65358147 P582 Q65358147-E6A1540A-3046-41D6-9F5C-4A433A8A9897 @default.
- Q65358147 P6099 Q65358147-46262E54-ACF6-443C-984A-FD9A9764814C @default.
- Q65358147 P8363 Q65358147-880B961B-39E0-4956-8C73-5E512334C804 @default.
- Q65358147 P1132 "+276" @default.
- Q65358147 P1476 "A Double Blind, Placebo Controlled Pivotal Phase III Study Evaluating Xilonix™ in Symptomatic Colorectal Cancer Patients Refractory to Standard Therapy" @default.
- Q65358147 P17 Q36 @default.
- Q65358147 P2899 "+18" @default.
- Q65358147 P3098 "NCT02138422" @default.
- Q65358147 P31 Q30612 @default.
- Q65358147 P580 "2014-07-01T00:00:00Z" @default.
- Q65358147 P582 "2015-11-01T00:00:00Z" @default.
- Q65358147 P6099 Q42824827 @default.
- Q65358147 P8363 Q78089383 @default.